FDA Approved: CLIMARA PRO — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLIMARA PRO, the estradiol/levonorgestrel transdermal patch from Bayer HealthCare Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis
• Vasomotor Symptoms Due to Menopause

Drugs mentioned

• CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)

Snippet

SUPPL AP for CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)